Continental Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-42,700
Closed -$1.58M 135
2016
Q4
$1.58M Sell
42,700
-3,300
-7% -$118K 0.43% 75
2016
Q3
$1.59M Hold
46,000
0.45% 69
2016
Q2
$1.5M Sell
46,000
-3,600
-7% -$110K 0.46% 69
2016
Q1
$1.43M Hold
49,600
0.4% 71
2015
Q4
$1.66M Buy
49,600
+17,700
+55% +$550K 0.42% 73
2015
Q3
$907K Buy
+31,900
New +$1.11M 0.24% 110

Other funds holding AVNS

Continental Advisors's AVNS Position: Q1 2017 in Review

Continental Advisors sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 42,700 shares — an estimated $1.58M sold.

Continental Advisors first reported a position in AVNS in Q3 2015 and held it in 6 quarters. The position peaked at $1.66M in Q4 2015. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • Continental Advisors reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • Continental Advisors sold 42,700 Avanos Medical shares in Q1 2017, an estimated $1.58M.
  • Continental Advisors first reported a position in Avanos Medical in Q3 2015 and held it in 6 quarters.
  • Continental Advisors's Avanos Medical position peaked at $1.66M in Q4 2015.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on Continental Advisors's 13F filing for Q1 2017, filed 15 May 2017.